The prevalence of gout in more affluent countries seems to be increasing in recent decades. Medications, co-morbidities, genetics and other risk factors are to blame.
The terminology used to describe gout in the medical literature is vague and sometimes confusing, new research finds.
The indirect costs of gout can be as much as $18,362 per patient each year, research shows.
Chronic consumption of sugar-sweetened beverages leads to increased BMI and gout risk, study shows.
Stress on joints appears to have no effect on urate deposition.
Patients with tophaceous gout rarely develop ulcers, but when they do occur, these ulcers can be difficult to treat. This case study explores the diagnosis of and treatment options for patients with ulcerated tophaceous gout.
Diagnosing gout can be vexing. Most of the time, the diagnosis is made in the primary care setting where physicians diagnose gout by following one of six classification criteria, with the most widely used one being the 1977 American Rheumatism Association criteria.
Four trials of moderate-quality evidence found no significant improvement in pain control in acute gout with NSAIDs vs COX inhibitors. But there was evidence that patients stopped NSAIDs early because of adverse events.
Gout attacks really do occur more often at night, and here is proof. Theories abound as to why, but effective prophylactic treatments to reduce the risk of nocturnal exacerbations appear to be just what the doctor ordered.
A large population study shows that people with gout may have a reduced risk of dementia -– including Alzheimer’s disease. This is a significant finding and may support theories that uric acid has antioxidant properties and possible neuroprotective effects.